Stay updated on Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Publications section now lists the NEJM article by Murthy et al. on tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer with full author names and citation details. The previous NEJM entry that included an erratum has been removed.
    Difference
    0.0%
    Check dated 2026-05-20T06:48:22.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a new revision label v3.5.3 and removed the previous v3.5.2, indicating an updated release version on the page. This appears to be a meta-level update rather than a change to study details or content.
    Difference
    0.0%
    Check dated 2026-04-28T08:12:37.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page’s displayed revision version was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-21T03:12:40.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Publication reference in the Publications section was updated: the NEJM 2020 Tucatinib paper is added and the prior NEJM citation is removed.
    Difference
    0.0%
    Check dated 2026-04-14T02:26:12.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0. No trial content or user-facing information was changed.
    Difference
    0.0%
    Check dated 2026-03-23T13:38:46.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-08T23:55:07.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.